Acne
No
Water Retention
No
HBR
No
Hepatotoxicity
No
Aromatization
No
Manufacturer
Beligas
Warehouse
International Warehouse 3
Substance
Anti-Obesity Drug-9604
Discover AOD 9604, a groundbreaking modified variant of Growth Hormone, designed specifically as a powerful peptide consisting of 191 amino acids. This innovative peptide includes the last 15 amino acids (176-191) of the Growth Hormone chain, known as GH Frag 176-191 or AOD 9604.
AOD 9604 is hailed as one of the most effective peptides for weight loss, delivering remarkable results in fat reduction and metabolism enhancement.
: Pituitary Gland
Stimulated GlandBenefits of AOD 9604Also referred to as Tyr-hGH Frag 176-191, AOD-9604 has demonstrated exceptional fat-burning capabilities without increasing appetite. It neither affects blood sugar nor promotes tissue growth. AOD-9604 effectively aids in fat degradation and oxidation without engaging the hGH receptor, operating through a unique mechanism distinct from hGH. Studies involving rodents, pigs, dogs, and humans showcase that AOD-9604 promotes fat release from primarily obese fat cells, while minimizing new fat formation and enhancing fat combustion, particularly targeting stubborn abdominal fat.
For those focused on fat loss, consider AOD-9604 rather than GHRP products like GHRP-6 or GHRP-2, which can increase hunger and cortisol levels. AOD-9604, on the other hand, does not trigger appetite or elevate cortisol.
Research on AOD 9604Originally developed in the 1990s by Professor Frank Ng at Monash University, AOD-9604 was crafted as an anti-obesity drug to emulate the fat-burning benefits of human growth hormone (HGH) without promoting muscle growth.
Recent studies have not only reinforced AOD 9604?s fat loss effectiveness but have also unveiled its regenerative properties linked to growth hormone. Ongoing research is investigating its potential to treat conditions such as osteoarthritis, high cholesterol, and support bone and cartilage repair.
Findings from oral glucose tolerance tests indicated that, unlike hGH, AOD 9604 does not negatively impact carbohydrate metabolism. No anti-AOD 9604 antibodies were detected in tested patients, and no serious adverse events related to AOD 9604 consumption were documented.
ConclusionAOD 9604 showcases an impressive safety and tolerability profile, mirroring that of a placebo, without the adverse effects associated with full-length hGH treatments. Its remarkable safety record has recently earned it Human GRAS status in the USA.

